LF
CRSP icon

LifeSteps Financial’s CRISPR Therapeutics CRSP Stock Holding History

LifeSteps Financial’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.64K Buy
+85
New +$4.48K ﹤0.01% 550

Other funds holding CRSP

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

LifeSteps Financial's CRSP Position: Q2 2026 in Review

LifeSteps Financial opened a new position in CRISPR Therapeutics (CRSP) in Q2 2026: 85 shares worth $4.64K. The stake represents ﹤0.01% of the portfolio and ranks #550 among its holdings.

159 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • LifeSteps Financial held 85 shares of CRISPR Therapeutics worth $4.64K as of Q2 2026.
  • CRISPR Therapeutics was a new LifeSteps Financial position in Q2 2026.
  • CRISPR Therapeutics made up ﹤0.01% of LifeSteps Financial's portfolio in Q2 2026, its #550 holding.
  • 159 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.